Clinical Trials Directory

Trials / Completed

CompletedNCT00134472

Therapeutic Hypothermia for Severe Traumatic Brain Injury in Japan

Therapeutic Strategy for Severe Head Trauma Patients With Mild Hypothermia and Estimation of Medical Expenses in Japan

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Yamaguchi University Hospital · Academic / Other
Sex
All
Age
15 Years – 69 Years
Healthy volunteers
Not accepted

Summary

The purpose of this trial is to determine if mild hypothermia therapy, for severe head trauma patients, improves neurological outcome.

Detailed description

Mild hypothermia therapy shows protective effects for damaged brains of animals and post cardiac arrest patients. However, Clifton et al. reported that mild hypothermia has no protective effect for severe head trauma but has a risk of complications. In this study, all the participants must be treated with continuous monitoring of cardiac output and jugular venous oxygen saturation to get optimal physiological conditions. Adequate anesthesia such as neuroleptanesthesia is essential to maintain organ function and tissue microcirculation. Participants are randomly assigned to two groups of mild hypothermia (32.0 - 34.0 degree Celsius) and anti-hyperthermia (35.5 - 37.0 C). The body temperature must be kept for at least 72 hours. Hypothermia must be induced within 6 hours after traumatic brain injury. Glasgow outcome score at 6 months after injury and the total medical expenses of the two groups will be evaluated.

Conditions

Interventions

TypeNameDescription
PROCEDURETherapeutic mild hypothermiaKeeping 32 - 34 degree celsius of core temperature at least for 72 hours.

Timeline

Start date
2002-12-01
Primary completion
2008-09-01
Completion
2008-09-01
First posted
2005-08-24
Last updated
2012-05-11

Locations

43 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT00134472. Inclusion in this directory is not an endorsement.